Literature DB >> 28875762

Predictors of infection in viral-hepatitis related acute liver failure.

Saurabh Kedia1, Hanish Sharma1, Sreejith Vasudevan1, Ujjwal Sonika1, Ashish Dutt Upadhyaya2, Subrat K Acharya1.   

Abstract

OBJECTIVE: Infections are common and associated with complications and mortality in acute liver failure (ALF). The temporal relationship between ammonia and infection in ALF patients is unclear. We aimed to evaluate the predictors of infection and its relationship with arterial ammonia levels.
MATERIALS AND METHODS: Consecutive ALF patients hospitalized between January 2004 and December 2015, without signs of infection at/within 48 h of admission, were included. Occurrence of infection after 48 h was documented and ammonia levels were estimated for five consecutive days. Multivariate logistic regression analysis was used to assess factors associated with development of infection. Generalized estimating equations (GEE) were used to evaluate five-day time trend of ammonia in patients with and without infection.
RESULTS: Of 540 consecutive patients, 120 were infected at admission/within 48 h and were excluded. Of the rest 420 patients, 144 (34.3%) developed infection after 48 h and 276 (65.7%) remained non-infected. Infected patients had higher mortality than non-infected patients (61.8% vs 40.0%, p < .001). On multivariate analysis, presence of cerebral edema(HR 2.049; 95%CI, 1.30-3.23), ammonia level on day 3 of admission (HR 1.006; 95%CI, 1.003-1.008), and model for end stage liver disease (MELD) score (HR 1.051; 95%CI, 1.026-1.078) were associated with development of infection. GEE showed group difference in serial ammonia values between infected and non-infected patients indicating lack of ammonia decline in infected patients.
CONCLUSIONS: Cerebral edema, elevated ammonia on day 3, and higher MELD score predict the development of infection in ALF. Ammonia persists at high levels in infected patients, and elevated ammonia on day 3 is associated with complications and death.

Entities:  

Keywords:  Acute hepatitis E; SIRS; anti-tubercular drugs; mortality; sepsis

Mesh:

Substances:

Year:  2017        PMID: 28875762     DOI: 10.1080/00365521.2017.1374449

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Acute Liver Failure of Non-A-E Viral Hepatitis Etiology-Profile, Prognosis, and Predictors of Outcome.

Authors:  Subrat K Acharya; Ramesh Kumar; Gangadhar Bharath; Gyanranjan Rout; Deepak Gunjan; Baibaswata Nayak
Journal:  J Clin Exp Hepatol       Date:  2020-01-16

2.  NLRP3 Inflammasome Activation is a Prognostic Marker of Recovery in HEV-Infected Patients.

Authors:  Vikram Thakur; Radha Kanta Ratho; Mini P Singh; Yogesh Chawla; Sunil Taneja
Journal:  Curr Microbiol       Date:  2022-01-04       Impact factor: 2.188

3.  Persistent or incident hyperammonemia is associated with poor outcomes in acute decompensation and acute-on-chronic liver failure.

Authors:  Gyanranjan Rout; Ramesh Kumar; Achintya D Singh; Sanchit Sharma; Deepak Gunjan; Anoop Saraya; Baibaswata Nayak; Subrat K Acharya
Journal:  JGH Open       Date:  2020-02-28

Review 4.  Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis.

Authors:  Anil C Anand; Bhaskar Nandi; Subrat K Acharya; Anil Arora; Sethu Babu; Yogesh Batra; Yogesh K Chawla; Abhijit Chowdhury; Ashok Chaoudhuri; Eapen C Eapen; Harshad Devarbhavi; RadhaKrishan Dhiman; Siddhartha Datta Gupta; Ajay Duseja; Dinesh Jothimani; Dharmesh Kapoor; Premashish Kar; Mohamad S Khuroo; Ashish Kumar; Kaushal Madan; Bipadabhanjan Mallick; Rakhi Maiwall; Neelam Mohan; Aabha Nagral; Preetam Nath; Sarat C Panigrahi; Ankush Pawar; Cyriac A Philips; Dibyalochan Prahraj; Pankaj Puri; Amit Rastogi; Vivek A Saraswat; Sanjiv Saigal; Akash Shukla; Shivaram P Singh; Thomas Verghese; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.